The overall PPV of biopsy using a PSA threshold of 3·0 ng/mL (ie, number of prostate cancers identified divided by number of prostate biopsies) was 51·4% (18 of 35; 95% CI 34·0–68·6; table 2). This evidence concerns the gene KLK3 and Familial prostate cancer.